Search results for: 'system cell'
- Related search terms
- cellphon insurance market
- cell ad gene therapeutics market
- cell biolog research market global 2024 2030
- cell biology research market global 2024 2024
- cell biolog research market global 2024 2024
-
20 Aug 2024  |  Global  |  Technology Research
Technological Advances in Regenerative Medicine
Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research
Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mese...
$4,950.00 -
05 Aug 2024  |  Global  |  Technology Research
CGT Research Outlook and Technology Growth Opportunities
CGT Landscape Assessment
The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...
$4,950.00 -
15 Jul 2024  |  Global  |  Technology Research
Connected Diabetes Care: Innovations and Growth Opportunities
Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management
The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and prevent the ...
$4,950.00 -
28 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...
$4,950.00 -
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00